XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income (loss) $ 26,000,000 $ (51,000,000) $ 209,000,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 146,000,000 115,000,000 104,000,000
Equity in (earnings) losses of unconsolidated affiliates 170,000,000 (30,000,000) (35,000,000)
Deferred income tax (benefit) expense 44,000,000 (40,000,000) (14,000,000)
Gain on disposition of assets (2,000,000) (18,000,000) (17,000,000)
Goodwill impairment 0 99,000,000 0
Asset impairments 2,000,000 98,000,000 0
Other 56,000,000 43,000,000 34,000,000
Changes in operating assets and liabilities, net of acquired businesses:      
Accounts receivable, net of allowance for credit losses (476,000,000) 127,000,000 (16,000,000)
Contract assets (48,000,000) 39,000,000 (31,000,000)
Claims receivable 0 29,000,000 39,000,000
Accounts payable 447,000,000 (40,000,000) 23,000,000
Contract liabilities (17,000,000) (134,000,000) 19,000,000
Accrued salaries, wages and benefits 38,000,000 38,000,000 (9,000,000)
Payments on operating lease liabilities (59,000,000) (61,000,000) (56,000,000)
Payments from unconsolidated affiliates, net 17,000,000 15,000,000 10,000,000
Distributions of earnings from unconsolidated affiliates 47,000,000 38,000,000 69,000,000
Pension funding (46,000,000) (46,000,000) (45,000,000)
Restructuring reserve (26,000,000) 89,000,000 0
Other assets and liabilities (41,000,000) 57,000,000 (28,000,000)
Total cash flows provided by operating activities 278,000,000 367,000,000 256,000,000
Cash flows from investing activities:      
Purchases of property, plant and equipment (30,000,000) (20,000,000) (20,000,000)
Proceeds from sale of assets or investments 44,000,000 1,000,000 9,000,000
Investments in equity method joint ventures (29,000,000) (26,000,000) (146,000,000)
Acquisitions of businesses, net of cash acquired (399,000,000) (832,000,000) 0
Acquisition of technology license (7,000,000) 0 0
Other (7,000,000) 0 (1,000,000)
Total cash flows used in investing activities (428,000,000) (877,000,000) (158,000,000)
Cash flows from financing activities:      
Borrowings on long term debt 164,000,000 359,000,000 0
Borrowings on revolving credit agreement 126,000,000 260,000,000 0
Payments on short-term and long-term borrowings (44,000,000) (281,000,000) (70,000,000)
Debt issuance costs (3,000,000) (5,000,000) 0
Payments of dividends to shareholders (61,000,000) (54,000,000) (46,000,000)
Net proceeds from issuance of common stock 12,000,000 4,000,000 5,000,000
Payments to reacquire common stock (82,000,000) (51,000,000) (4,000,000)
Distributions to noncontrolling interests (23,000,000) (4,000,000) (14,000,000)
Other (2,000,000) (3,000,000) (4,000,000)
Total cash flows provided by (used in) financing activities 87,000,000 225,000,000 (133,000,000)
Effect of exchange rate changes on cash (3,000,000) 9,000,000 8,000,000
Decrease in cash and equivalents (66,000,000) (276,000,000) (27,000,000)
Cash and equivalents at beginning of period 436,000,000 712,000,000 739,000,000
Cash and equivalents at end of period 370,000,000 436,000,000 712,000,000
Supplemental disclosure of cash flows information:      
Cash paid for interest 63,000,000 53,000,000 80,000,000
Cash paid for income taxes (net of refunds) 49,000,000 49,000,000 54,000,000
Noncash financing activities      
Dividends declared $ 15,000,000 $ 14,000,000 $ 11,000,000